Balanced news tone
News Sentiment
ABL sentiment intelligence
Abbott Laboratories news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Weighted score
52
Balanced news tone
22 relevant articles
News tone and price action are not far from neutral.
83/100 classification confidence.
directly relevant articles
high-authority source matches
-1.5% over one week, +7.7% over four weeks, trend inactive, and near fair-value range.
Abbott Laboratories Stock Draws Fresh Targets As Growth Story Builds
Market Reaction
Balanced read
News tone and price action are not far from neutral.
Primary event
Market update
83/100 classification
One-week reaction
-1.5%
Price digesting
Trend fit
Trend inactive
7.7% over four weeks
Fair value
-17.5%
Near fair-value range
Market Dynamics buy signal
Sentiment Mix
Positive, neutral, negative
Positive
3
Neutral
18
Negative
1
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
Above 50
Neutral zone
Below 50
News Tape
Relevant headlines
StocksToTrade
Direct company coverage
Abbott Laboratories Stock Draws Fresh Targets As Growth Story Builds
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 16 Jul 2026 20:03
- Source
- StocksToTrade
Investing.com UK
Direct company coverage
Why is Abbott Laboratories stock surging today? By Investing.com
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 16 Jul 2026 11:54
- Source
- Investing.com UK
TechStock²
Direct company coverage
Healthcare Stocks: J&J, UnitedHealth, Abbott Face Test on Sector’s 9% Earnings Drop
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 12 Jul 2026 21:01
- Source
- TechStock²
Market source
Direct company coverage
Is Abbott Laboratories (ABT) Stock Still a Healthcare Growth Opportunity After Analyst Target Cut?
- Tone
- Neutral 50/100
- Event
- Analyst action
- Published
- 08 Jul 2026 07:00
- Source
- Market source
Stock Titan
Direct company coverage
Abbott Laboratories (ABT) director granted 416 stock equivalent units as board fees
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 01 Jul 2026 07:00
- Source
- Stock Titan
Stock Titan
Direct company coverage
Abbott (ABT) EVP Cushman disposes 560 shares for tax withholding, retains 38,013
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 29 Jun 2026 07:00
- Source
- Stock Titan
Stock Titan
Direct company coverage
Abbott to post Q2 results July 16, then host live webcast
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 25 Jun 2026 07:00
- Source
- Stock Titan
ad-hoc-news.de
Direct company coverage
Abbott Laboratories confirms CE mark for dual sensor, shares in S&P 500 healthcare focus
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 23 Jun 2026 07:00
- Source
- ad-hoc-news.de
GuruFocus
Direct company coverage
Is It Too Late to Buy Abbott Laboratories (ABT) After 4.4% Rally? GF Value Says Undervalued
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 04 Jun 2026 07:00
- Source
- GuruFocus
ad-hoc-news.de
Direct company coverage
Abbott Laboratories stock (US0028241000): U.S. healthcare name steadies after recent slide as instit
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 03 Jun 2026 07:00
- Source
- ad-hoc-news.de
ad-hoc-news.de
Direct company coverage
Abbott Laboratories stock (US0028241000): U.S. healthcare name steadies after recent ETF inclusion a
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 31 May 2026 07:00
- Source
- ad-hoc-news.de
IndexBox
Direct company coverage
Abbott Laboratories, Coca-Cola, and Walmart: Top Recession-Proof Stocks for 2026 - News and Statistics
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 22 May 2026 07:00
- Source
- IndexBox
GuruFocus
Direct company coverage
ABT: Abbott Laboratories Director Acquires 10,000 Shares Amid De
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 02 May 2026 07:00
- Source
- GuruFocus
Market source
Direct company coverage
Abbott Laboratories (ABT) Receives FDA Clearance and CE Mark for Next-Generation Ultreon™ 3.0 Software
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 01 May 2026 07:00
- Source
- Market source
Stock Titan
Direct company coverage
Abbott (NYSE: ABT) CFO adds 2,200 shares in open-market buy
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 27 Apr 2026 07:00
- Source
- Stock Titan
Seeking Alpha
Direct company coverage
Abbott is the most oversold healthcare stock as Q1 earnings roll on (XLV:NYSEARCA)
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 22 Apr 2026 07:00
- Source
- Seeking Alpha
Stock Titan
Direct company coverage
Abbott (ABT) director Gonzalez receives 321 stock equivalent units as fees
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 02 Apr 2026 07:00
- Source
- Stock Titan
IndexBox
Direct company coverage
Abbott Labs Q4 2025: Revenue Miss, Device Growth & Exact Sciences Acquisition - News and Statistics
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 19 Mar 2026 07:00
- Source
- IndexBox
Market source
Direct company coverage
Q4 Earnings Highs And Lows: Abbott Laboratories (NYSE:ABT) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 12 Mar 2026 07:00
- Source
- Market source
TIKR.com
Direct company coverage
After a 15% Drop, Is Abbott Stock Set Up for a Comeback in 2026?
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 10 Feb 2026 08:00
- Source
- TIKR.com
Bloomberg.com
Direct company coverage
Abbott Stock (ABT) Drops on Lower Full-Year Outlook; Sales Meet Estimates
- Tone
- Negative 34/100
- Event
- Guidance
- Published
- 17 Jul 2025 07:00
- Source
- Bloomberg.com
Reuters
Direct company coverage
Abbott shares slide after trial verdict, weigh on rival Reckitt Benckiser
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 29 Jul 2024 07:00
- Source
- Reuters